The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,610.00
Bid: 1,612.00
Ask: 1,614.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.124%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,610.00
SCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Chief Financial Officer Appointment

2 Dec 2022 07:00

RNS Number : 3454I
Softcat PLC
02 December 2022
 

2 December 2022

 

Softcat plc

 

Chief Financial Officer Appointment

 

 

The Board of Softcat plc ("Softcat", or the "Company"), a leading UK provider of IT infrastructure technology and services, is pleased to announce the appointment of Dr Kathryn (Katy) Mecklenburgh as CFO.

 

In July of this year, the Board outlined a series of steps designed to ensure continued, effective leadership of the Company and orderly succession over the medium term. A key element of this plan is the intention for the current CFO, Graham Charlton, to become CEO of Softcat with effect from 1 August 2023. In order to support this transition, a full internal and external search process was initiated to identify a replacement CFO candidate. That process has now successfully concluded.

 

Katy Mecklenburgh is a senior finance professional, who has held a number of finance leadership roles across a range of industries and blue-chip firms, including Amazon, Serco plc and Procter & Gamble. Katy is currently Interim CFO at ASOS plc, the FTSE 250 e-commerce business. In this role, Katy has responsibility not only for group finance and audit matters but also commercial finance and external financial reporting. Prior to joining ASOS plc in 2021, Katy served as Group Financial Controller at Inchcape plc, a firm with an annual turnover of c.£8 billion across c.40 markets and territories: a role she held since 2017.

 

CIMA qualified, Katy also holds a PhD in Respiratory Medicine and a BSC Hons in Pharmacology, both from Edinburgh University.

 

Katy will join the Softcat Board by no later than mid-June 2023. When she joins the Board, Graham Charlton will become CEO Designate, before he becomes CEO on 1 August 2023, in line with the planned and previously announced succession steps.

 

Martin Hellawell, Non-Executive Chairman said:

 

"We conducted an extensive, rigorous search for our new CFO and are delighted to have found someone of Katy's calibre and mindset. Katy's background, experience and affinity with our culture and workforce set her apart from other candidates. She will make a hugely valuable addition to our Board and Senior Leadership Team and her appointment allows us to deliver on our stated goal of ensuring the continued, effective and long-term leadership of our company."

 

Graeme Watt, Chief Executive Officer said:

 

"I am very excited that Katy is joining us. She is a great cultural fit and I am sure she will thrive in the Softcat environment as well as bring a lot of expertise and experience from other industries. She joins not only as CFO but also as a key member of our Senior Leadership Team, and the different perspectives she will provide will be most valuable. She has worked for a number of technology-based companies and will have an important contribution to make to our data and digital journey as we take Softcat to the next level."

 

Katy Mecklenburgh said:

 

"I am delighted to be joining Softcat as they continue to deliver their successful growth strategy. Softcat is a fantastic company, and I am looking forward to making my own contribution to a business with such a strong service and people orientated culture."

 

 

Regulatory Disclosures

 

No details need to be disclosed under Listing Rule 9.6.13 in relation to this appointment.

 

A further regulatory announcement will be made when the date that Katy Mecklenburgh will join the Board has been confirmed.

 

 

For further information, please contact:

 

Softcat plc

Graeme Watt, Chief Executive Officer +44 (0)1628 403 610

Graham Charlton, Chief Financial Officer

 

Media Enquiries FTI Consulting LLP

Ed Bridges/Matt Dixon +44 (0)20 3727 1000

 

 

This announcement has been determined to contain inside information.

 

 

 

Remuneration in respect of Katy Mecklenburgh:

All remuneration terms and payments will be in line with the current Directors' Remuneration Policy (the Policy) and the Policy to be proposed at Softcat's Annual General Meeting on 13 December 2022. When Katy Mecklenburgh's appointment commences, she will receive a salary of £370,000 per annum. In line with arrangements for current Executive Directors, the maximum variable incentive opportunity will be 150% of salary under the Annual Bonus Plan and 150% of salary under the Long Term Incentive Plan.

 

Katy Mecklenburgh will be compensated in respect of certain variable compensation which will be forfeited as a result of her resignation from ASOS plc. She will receive a cash payment in lieu of a forfeited retention award from ASOS plc. The cash payment will be based on the value of the ASOS shares in the retention award which was due to vest on 30 April 2023. The payment will be subject to income tax and national insurance deductions.

 

Full disclosure of these remuneration arrangements will be provided in our 2023 Annual Report on Directors' Remuneration.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRBDDGUGDGDB
Date   Source Headline
1st May 202410:50 amRNSTotal Voting Rights
9th Apr 20249:45 amRNSDirector/PDMR Shareholding
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20241:00 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSHalf-year Report
15th Mar 20242:45 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSNotice of Results
1st Mar 20242:28 pmRNSHolding(s) in Company
1st Mar 202410:47 amRNSTotal Voting Rights
8th Feb 20249:34 amRNSDirector/PDMR Shareholding
1st Feb 20249:49 amRNSTotal Voting Rights
30th Jan 20249:58 amRNSHolding(s) in Company
9th Jan 20243:48 pmRNSDirector/PDMR Shareholding
9th Jan 202412:42 pmRNSHolding(s) in Company
2nd Jan 20249:50 amRNSTotal Voting Rights
18th Dec 20239:58 amRNSBlock listing Interim Review
14th Dec 202311:29 amRNSDirector/PDMR Shareholding
14th Dec 202311:25 amRNSResult of AGM
12th Dec 20234:20 pmRNSDirector/PDMR Shareholding
8th Dec 20231:02 pmRNSDirector/PDMR Shareholding
1st Dec 20233:58 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSQ1 2024 Trading Update
24th Nov 20234:54 pmRNSDirector/PDMR Shareholding
24th Nov 20234:51 pmRNSDirector/PDMR Shareholding
8th Nov 20233:22 pmRNSDirector/PDMR Shareholding
1st Nov 202310:08 amRNSAnnual Financial Report and Notice of AGM
24th Oct 20237:00 amRNSFinal Results
10th Oct 202310:40 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSNotice of Results
2nd Oct 202310:38 amRNSTotal Voting Rights
8th Sep 20232:32 pmRNSDirector/PDMR Shareholding
1st Sep 202310:04 amRNSTotal Voting Rights
10th Aug 202310:59 amRNSDirector/PDMR Shareholding
1st Aug 202312:22 pmRNSTotal Voting Rights
1st Aug 20237:00 amRNSAppointment of Non-Executive Directors
10th Jul 20232:10 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:19 amRNSTotal Voting Rights
8th Jun 202311:23 amRNSDirector/PDMR Shareholding
1st Jun 202312:32 pmRNSTotal Voting Rights
1st Jun 202311:08 amRNSBlock listing Interim Review
30th May 20237:00 amRNSQ3 2023 Trading Update
25th May 20238:47 amRNSDirector Declaration
10th May 20238:59 amRNSDirector/PDMR Shareholding
2nd May 20235:08 pmRNSTotal Voting Rights
12th Apr 202310:14 amRNSDirector/PDMR Shareholding
3rd Apr 20239:34 amRNSTotal Voting Rights
28th Mar 20237:00 amRNSHalf-year Report
16th Mar 20232:39 pmRNSConfirmation of CFO Appointment Date
15th Mar 20237:00 amRNSNotice of Results
9th Mar 20232:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.